Mechanism of Improvement in Glucose Metabolism After Chronic Glyburide Therapy
暂无分享,去创建一个
R. DeFronzo | E. Barrett | E. Ferrannini | D. Simonson | S. Bevilacqua | Douglas Smith | R. Carlson | Ralph A. DeFronzo | Eleuterio Ferrannini | Donald C. Simonson | R. A. DeFronzo | Eugene Barrett | Rodney Carlson | Eugene J. Barrett
[1] E. Tsalikian,et al. The Effect of Chronic Oral Antidiabetic Therapy on Insulin and Glucagon Responses to a Meal , 1977, Diabetes.
[2] H. Lebovitz,et al. An Insulin Dependent Effect of Chronic Tolbutamide Administration on the Skeletal Muscle Carbohydrate Transport System , 1969, Diabetes.
[3] A. Barnes,et al. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose. , 1974, Lancet.
[4] S. Blumenthal. Potentiation of the Hepatic Action of Insulin by Chlorpropamide , 1977, Diabetes.
[5] Rafaelsen Oj. Action of oral antidiabetic drugs on carbohydrate metabolism of isolated rat diaphragm. , 1959 .
[6] G. Pogátsa,et al. DIRECT INHIBITION OF HEPATIC GLYCOGENOLYSIS BY TOLBUTAMIDE , 1960 .
[7] G. Reaven,et al. Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? , 1976, The American journal of medicine.
[8] G. Reaven,et al. Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. , 1975, The Journal of clinical investigation.
[9] A. Colwell. POTENTIATION OF INSULIN ACTION ON THE LIVER BY TOLBUTAMIDE. , 1964, Metabolism: clinical and experimental.
[10] H. Lebovitz,et al. Sulphonylureas increase the number of insulin receptors , 1978, Nature.
[11] G. Grunberger,et al. Sulfonylureas Do Not Affect Insulin Binding or Glycemic Control in Insulin-dependent Diabetics , 1982, Diabetes.
[12] J. Penhos,et al. ACTION OF THE HYPOGLYCEMIC SULFONYL COMPOUNDS IN HYPOPHYSECTOMIZED, ADRENALECTOMIZED, AND DEPANCREATIZED ANIMALS , 1957, Annals of the New York Academy of Sciences.
[13] R. DeFronzo,et al. Insulin resistance in uremia mediated by postbinding defects. , 1982, Kidney international.
[14] F. Davidoff. Hepatic effects of oral hypoglycemic drugs. , 1977, Federation proceedings.
[15] G. Reaven,et al. Effect of Sulfonylurea Treatment on In Vivo Insulin Secretion and Action in Patients With Non-insulin-dependent Diabetes Mellitus , 1982, Diabetes.
[16] R. DeFronzo,et al. Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[17] G. Reaven,et al. Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus , 1967, Diabetes.
[18] H. Ginsberg,et al. Effect of Insulin Therapy on Insulin Resistance in Type II Diabetic Subjects: Evidence for Heterogeneity , 1981, Diabetes.
[19] E. Cerasi,et al. Insulin release, insulin sensitivity, and glucose intolerance. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Arson. The Significance and Interpretation of Mildly Abnormal Oral Glucose Tolerance , 1971 .
[21] S. Berson,et al. Separation of Antibody-Bound and Unbound Peptide Hormones Labelled with Iodine-131 by Talcum Powder and Precipitated Silica , 1966, Nature.
[22] R. B. Kerr,et al. Insulin-sensitive and insulin-insensitive types of diabetes mellitus. , 1939 .
[23] J. Halter,et al. The Effect of Chronic Sulfonylurea Therapy on Hepatic Glucose Production in Non-insulin-dependent Diabetes , 1982, Diabetes.
[24] R. Steele,et al. INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.
[25] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[26] R. Jones,et al. Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide. , 1981, The Journal of clinical investigation.
[27] C. J. Goodner,et al. The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. , 1968, Annals of internal medicine.
[28] L. Mandarino,et al. Mechanism and Significance of Insulin Resistance in Non-insulin-dependent Diabetes Mellitus , 1981, Diabetes.
[29] W. Duckworth,et al. Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels. , 1972, The Journal of clinical endocrinology and metabolism.
[30] E. Cerasi,et al. Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjects. , 1979, Acta endocrinologica.
[31] S. Berson,et al. Comparison of Plasma Insulin Levels Following Administration of Tolbutamide and Glucose , 1960, Diabetes.
[32] R. DeFronzo,et al. The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. , 1980, Metabolism: clinical and experimental.